Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method-Reference-Cited by-同舟云学术

Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method

Published:2014-10-30 Issue:5 Volume:56 Page:1416-1424
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Manasanch Elisabet E.,Salem Dalia A.,Yuan Constance M.,Tageja Nishant,Bhutani Manisha,Kwok Mary,Kazandjian Dickran,Carter George,Steinberg Seth M.,Zuchlinski Diamond,Mulquin Marcia,Calvo Katherine,Maric Irina,Roschewski Mark,Korde Neha,Braylan Raul,Landgren Ola,Stetler-Stevenson Maryalice

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.955020

Reference45 articles.

1. Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

2. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells

3. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

4. Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

5. Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normal and malignant cells are homogeneously distributed in the bone marrow of children;Leukemia & Lymphoma;2024-04-08

2. Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index;Blood Cancer Journal;2023-12-01

3. Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain;Molecular Therapy;2023-12

4. Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders;Clinics in Laboratory Medicine;2023-09

5. Immunophenotypic Profile of Multiple Myeloma: A Tertiary Care Centre Experience;Journal of Laboratory Physicians;2023-01-30